25 results on '"Hofmann W. -K."'
Search Results
2. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillusspecific nested polymerase chain reaction in a prospective pilot study
3. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients
4. Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2/ASXL1/RUNX1gene panel are strong adverse prognostic markers in patients with systemic mastocytosis
5. Prevalence, clonal dynamics and clinical impact of TP53mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)
6. Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
7. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV
8. Additional mutations in SRSF2, ASXL1and/or RUNX1identify a high-risk group of patients with KITD816V+advanced systemic mastocytosis
9. Cytogenetically cryptic ZMYM2-FLT3and DIAPH1-PDGFRBgene fusions in myeloid neoplasms with eosinophilia
10. AspergillusPCR-Based Investigation of Fresh Tissue and Effusion Samples in Patients with Suspected Invasive Aspergillosis Enhances Diagnostic Capabilities
11. Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes
12. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias
13. Transforming growth factor-b1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells
14. Platelet Glycoprotein Expression in Patients with Myelodysplastic Syndrome
15. Alteration of c-mpl-mediated signal transduction in CD34+ cells from patients with myelodysplastic syndromes
16. Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes
17. Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor
18. Comparison of toxicity and outcome in patients with acute myeloid leukemia treated with high-dose cytosine arabinoside consolidation after induction with a regimen containing idarubicin or daunorubicin
19. Erratum: Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
20. Identification of Epigenetically Silenced Tumor Suppressor Genes in Myeloid Disorders Leads to the Identification of α-Catenin as a Target Gene in 5q- Syndrome.
21. ChemInform Abstract: Ternary Pnictides MNi2‐xPn2 (M: Sr and Rare Earth Metals, Pn: Sb, Bi) with Defect CaBe2Ge2 and Defect ThCr2Si2 Structures
22. 189 Infectious complications after intensive remission induction in advanced myelodysplastic syndromes and de novoacute myeloid leukemia
23. 150 Treatment of low-risk MDS: Combination of hematopoietic growth factors and biological response modifiers
24. ChemInform Abstract: Lanthanoid and Uranium Nickel Arsenides with CaBe2Ge2‐ and ThCr2Si2‐Type Structures.
25. 84 In vitro effect of c-mpl-ligand on CD34 positive cells isolated from patients with chronic myelodysplastic syndromes (MDS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.